NASDAQ: LTGO
Latigo Biotherapeutics Inc Stock Ownership - Who owns Latigo Biotherapeutics?

Insider buying vs selling

Have Latigo Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Foresite Capital Management V LLC10% Owner2026-08-10140,000$18.00
$2.52MBuy
James B. TananbaumDirector2026-08-10140,000$18.00
$2.52MBuy

1 of 1

LTGO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LTGO insiders and whales buy or sell their stock.

LTGO Shareholders

What type of owners hold Latigo Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
5am Ventures VI LP11.05%7,325,962$96.04MInsider
Foresite Capital Management V LLC5.15%3,414,544$44.76MInsider
James B. Tananbaum5.15%3,414,544$44.76MInsider
Beth C. Seidenberg3.16%2,094,813$27.46MInsider
Westlake Biopartners Fund I LP3.16%2,094,813$27.46MInsider
Sanofi1.01%672,788$8.82MInsider
Nima Farzan0.17%114,453$1.50MInsider
Blue Owl Capital Holdings LP0.01%3,596$47.14kInstitution
Fmr LLC0.00%2,879$37.74kInstitution
Aberdeen Group PLC0.00%935$12.26kInstitution

1 of 3

LTGO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LTGO0.02%28.86%Net Buying
IVA0.02%0.00%
SNDX0.05%10.32%Net SellingNet Buying
PHAR0.00%0.00%
MGTX0.04%49.32%Net SellingNet Selling

Latigo Biotherapeutics Stock Ownership FAQ

Who owns Latigo Biotherapeutics?

Latigo Biotherapeutics (NASDAQ: LTGO) is owned by 0.02% institutional shareholders, 28.86% Latigo Biotherapeutics insiders, and 71.13% retail investors. 5am Ventures VI LP is the largest individual Latigo Biotherapeutics shareholder, owning 7.33M shares representing 11.05% of the company. 5am Ventures VI LP's Latigo Biotherapeutics shares are currently valued at $96.04M.

If you're new to stock investing, here's how to buy Latigo Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.